Myriad Genetics board member steps down
(AP) — Molecular diagnostics company Myriad Genetics Inc. said Tuesday Dr. Mark Skolnick will step down from its board of directors.
Skolnick will remain with the company as a part-time employee in the capacity of senior scientist emeritus. He has served on the board since 1991.
On June 30, the company completed a spin-off of its former research and drug development businesses, which now make up a separate publicly traded company called Myriad Pharmaceuticals.
Memorial Day 2026: NewsdayTV honors those we've lost A brave young patriot receives a burial 83 years after being lost in war. Volunteers restore a Revolutionary War cemetery. A Gold Star mom makes it her mission to honor her son's sacrifice. NewsdayTV's Virginia Huie shares three stories in honor of Memorial Day.
Memorial Day 2026: NewsdayTV honors those we've lost A brave young patriot receives a burial 83 years after being lost in war. Volunteers restore a Revolutionary War cemetery. A Gold Star mom makes it her mission to honor her son's sacrifice. NewsdayTV's Virginia Huie shares three stories in honor of Memorial Day.
